Trial Profile
Safety and efficacy of transarterial chemoembolization using doxorubicin eluting beads in patients with unresectable HCC.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 16 Dec 2015 New trial record